Core Value of R&D Technology

R&D Advantages

1.Proprietary Tissue-Processing Technology
Established capabilities spanning human tissue processing, decellularization, freeze-drying, and terminal sterilization.

2. ECM Preservation Technology
Focused on preserving the natural extracellular matrix (ECM) structure and material properties of human tissues.

3. Diversified Tissue R&D Platform
A cross-product development platform encompassing amniotic membrane, dermal tissue, cartilage, and bone tissue.

4. Process Parameter Optimization
Processing conditions are tailored to different tissue characteristics to balance structural integrity, handling performance, and quality consistency.

5. Comprehensive Quality Testing
Product quality is evaluated through histological, biological, chemical, and microbiological testing.

6. Regulatory-Driven R&D Design
GTP, TFDA, and applicable quality requirements are incorporated from the early stages of development to facilitate regulatory alignment.

7. Clinically Driven Product Development
Multiple formats—including membranes, powders, granules, and fibers—are developed to address the procedural needs of different specialties.

8. Integrated R&D-to-Manufacturing Capabilities
R&D, manufacturing, quality assurance, regulatory affairs, and clinical applications are integrated to improve commercialization efficiency.

Core R&D Highlights

1. Clinically Driven Innovation
Product development begins with physicians’ procedural needs and real-world clinical settings.

2. Cross-Disciplinary R&D Integration
Expertise in biomaterials, tissue engineering, manufacturing, quality assurance, and regulatory affairs is integrated to accelerate product development.

3. Platform-Based Development
R&D platforms built around amniotic, dermal, and bone tissues support the development of multiple specifications and product formats.

4. Data-Driven Product Optimization
Experimental and quality data are continuously evaluated to guide process optimization and product design.

5. Academic and Clinical Collaboration
Academic expertise and clinical experience are combined to explore new applications for human tissue materials.

6. R&D and Commercialization in Parallel
Development encompasses not only laboratory outcomes but also scalable manufacturing, quality, regulatory, and clinical-use considerations.

7. Continuous Development of In-House R&D Capabilities
Experience in tissue materials, manufacturing processes, and analytical methods is continuously accumulated to build long-term technological assets.